These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1.
    Journal: AIDS Treat News; 1999 Jun 18; (No 321):8. PubMed ID: 11366716.
    Abstract:
    A bill (H.R. 1598) to extend the patents on Claritin and a half dozen other drugs is scheduled for a congressional hearing on July 1. While the legislation does not affect AIDS drugs, activists fear the setting of a precedent when AIDS drugs go off patent in coming years. Schering, Claritin's manufacturer, is financing a huge effort to have the patent extension bill passed. Information is provided for those wanting more information about H.R. 1598.
    [Abstract] [Full Text] [Related] [New Search]